3 Things to Know About Cobenfy, the New Schizophrenia Drug
3 days ago · Cobenfy is the first treatment for the disease to use a new mechanism to ease symptoms, such as hearing voices and hallucinations, without debilitating side effects. [Originally published: Nov. 12, 2024. Updated: Jan. 6, 2025.]
Schizophrenia Today: What's New and What's Coming
Jan 1, 2025 · Experts in schizophrenia research and treatment offer glimpses of the future. "Who's Who in Schizophrenia?" refines and replaces older conceptualizations of this mental disorder. Treatment of...
Emerging Approaches in Schizophrenia - psychiatrist.com
Dec 12, 2024 · This collection from Psychiatrist.com News highlights the latest developments in schizophrenia treatment, emphasizing new therapies that go beyond traditional dopaminergic approaches. Clinicians will gain insights into managing symptoms, cognitive impairments, and the functional, emotional, and economic burdens of schizophrenia.
FDA approves Cobenfy: A breakthrough in schizophrenia …
Dec 11, 2024 · In late September, health experts at the U.S. Food and Drug Administration (FDA) announced approval of a new drug, Cobenfy, that offers a new mechanism for treating schizophrenia – one that does not target dopamine directly and shows promise in not only relieving symptoms but also reducing the punishing side effects.
Brain Mapping Approach Reveals Hidden Clues to Schizophrenia
Nov 21, 2024 · A new study identifies previously hidden brain network patterns in schizophrenia by focusing on nonlinear connectivity, offering potential biomarkers for early diagnosis.
Brain Connectivity Linked With Cognition in People With Early
Dec 16, 2024 · People with psychotic disorders like schizophrenia frequently experience cognitive difficulties, including problems with attention, concentration, and memory. These cognitive difficulties are often early symptoms that appear before the onset of psychosis. In a study funded by the National Institute of Mental Health, researchers identified ...
First new type of treatment for schizophrenia in decades - NPR
Sep 27, 2024 · A medicine that sidesteps the brain's dopamine receptors to reach different targets represents a new approach to schizophrenia treatment. The Food and Drug Administration approved it Thursday.
Schizophrenia News - ScienceDaily
Read current medical research on schizophrenia symptoms, medication and more. Browse health articles on schizophrenia treatments including anti-psychotic drugs.
24, and Trying to Outrun Schizophrenia - The New York Times
Dec 30, 2024 · This is not unusual; a Swedish study found that five years after diagnosis, only 10 percent of people with schizophrenia were employed. The median long-term recovery rate, according to a 2013 meta ...
Study on origins of schizophrenia in the brain offers hope for …
Jul 16, 2024 · A group of scientists are hopeful their research findings about how schizophrenia originates and develops over time in the brain will pave the way for targeted treatments and better diagnosis of...